30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

HILLHOUSE INVESTMENT MANAGEMENT, LTD.

Insider profile

Performance

Overall performance
1.6

Performance over holding periods
1.6
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s trades of Arrivent Biopharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-03 2025-12-10 S Sale
40,435 +24.5%
449.36
US$1,011,716
40,435 +24.5% 449.36 US$1,011,716
2024-02-01 2024-01-30 B Purchase
20,100 +33.1%
320.22
US$4,848,610
20,100 +33.1% 320.22 US$4,848,610
2021-10-27 2021-10-25 S Sale
84,450 +17.9%
23.51
US$3,789,388
84,450 +17.9% 23.51 US$3,789,388